During the past decade, Instituto de Ginecología y Reproducción conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto de Ginecología y Reproducción" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Human Genome Sciences Inc." with 1 trials sponsored, "Ipsen" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Rigel Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Ginecología y Reproducción" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Instituto de Ginecología y Reproducción" are "Lupus Nephritis" (3 trials), "Rheumatoid Arthritis" (2 trials), "Systemic Lupus Erythematosus" (2 trials), "Arthritis, Rheumatoid" (1 trials) and "Overactive Bladder" (1 trials). Many other conditions were trialed in "Instituto de Ginecología y Reproducción" in a lesser frequency.

Most popular intervention types in "Instituto de Ginecología y Reproducción" are "Drug" (9 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Methylprednisolone" (4 trials), "Obinutuzumab" (4 trials), "Prednisone" (3 trials) and "Acetaminophen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Ginecología y Reproducción" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Instituto de Ginecología y Reproducción". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Instituto de Ginecología y Reproducción, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Ginecología y Reproducción, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".